Global Tolbutamide (CAS 64-77-7) Market Research Report 2021

Tolbutamide (CAS 64-77-7), C12H18N2O3S, the formula weight is 270.35, and its form is white crystal powder.
Tolbutamide is suitable for the treatment of type 2 diabetes. Tolubutamide should be used in patients with high blood sugar after diet control and exercise therapy. Because of the mildening of tolbutamide, it is more suitable for mild and moderate elderly patients with diabetes.

The global Tolbutamide (CAS 64-77-7) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Tolbutamide (CAS 64-77-7) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Tolbutamide (CAS 64-77-7) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Tolbutamide (CAS 64-77-7) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Oral
Injection

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pengyao Pharma
SINE
Changzhou Pharma
Changjiang Pharma
EASHU Pharma
Mylan
Sovereign
Vexxa LifeScience
Genesis Pharma

Frequently Asked Questions